T he CXCL8 belongs to the CXC subfamily of chemokines that mediates neutrophil accumulation and activation at the site of inflammation and infection. These functions are mediated by binding to two cell surface receptors, CXCR1 and CXCR2 (1, 2) . CXCR1 is specific for CXCL8, whereas CXCR2 is promiscuous and also interacts with CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, and CXCL7 (3). Upon activation, both receptors couple to pertussis toxin-sensitive G protein to mediate phosphoinositide (PI) 3 hydrolysis, intracellular Ca 2ϩ mobilization, chemotaxis, and exocytosis (4, 5) .
A characteristic feature of chemokines, including CXCL8, is their ability to reversibly exist as both monomers and dimers (6) . During active neutrophil recruitment, CXCL8 concentrations could vary spatially and temporally and reach high levels so that both monomers and dimers exist at different locations and time points, suggesting that both forms play an active role in recruitment and inflammatory response. Previous studies using a nonassociating "trapped" monomer (L25NMe) and a nondissociating trapped dimer (R26C) of CXCL8 have shown that the monomer is the high-affinity ligand, and the dimer is the low-affinity ligand for both receptors (7) (8) (9) . However, a knowledge of the ligand-binding affinities alone is not sufficient to understand receptor-mediated cellular function. Function is a downstream event that is a consequence of receptor binding and differences in binding affinities could be attenuated or amplified.
Like many G-protein coupled receptors (GPCRs) on leukocytes, CXCR1 and CXCR2 become phosphorylated, desensitized, and internalized upon activation by CXCL8. Previous studies using wild-type (WT) CXCL8 have shown that CXCR2, compared with CXCR1, internalizes more rapidly and recovers more slowly (4, 5, 10 -13) . These differences in receptor trafficking appear to be important factors that influence how and to what extent and how the individual receptors mediate neutrophil recruitment and activation (4, 5, 14) .
To date, little is known about how monomeric and dimeric forms of CXCL8 regulate CXCR1 and CXCR2 functions. In the present work, we sought to determine the role of the two forms of CXCL8 in mediating various receptor activities and their downregulation and trafficking. To that end, rat basophilic leukemia (RBL-2H3) cells stably expressing CXCR1 or CXCR2 were generated. The ability of the monomer and dimer forms to mediate different receptor activities such as phosphorylation, desensitization, arrestin translocation, and internalization were compared with WT CXCL8. The data herein indicate that the monomer and dimer modulate differently the desensitization and trafficking of CXCR1, but not of CXCR2. We propose that these distinct properties of the monomer and dimer forms of the two receptors play an essential role in mediating neutrophil trafficking and eliciting cytotoxic activities at the site of inflammation. 125 I-labeled CXCL8 were purchased from PerkinElmer. Geneticin (G418) and all tissue culture reagents were purchased from Invitrogen. Human microvascular endothelial cells (HMECs) were either purchased from 3H Biomedical or obtained from Dr. R. Singh's laboratory (University of Nebraska Medical Center, Omaha, NE). Monoclonal 12CA5 Ab, protein G-agarose, and protease inhibitors were purchased from Roche Diagnostics. Anti-human IL-8RA (CXCR1) and IL-8RB (CXCR2) Abs were purchased from BD Pharmingen. PMA was purchased from Sigma-Aldrich. All other reagents are from commercial sources.
Materials and Methods

Materials
Ligand synthesis
The trapped R26C disulfide-linked dimer and the trapped L25NMe monomer were synthesized using solid-phase peptide synthesis and purified by reversed-phase HPLC, and the WT was produced using recombinant methods as described previously (15, 16) .
Cell culture and transfection
RBL-2H3 cells were maintained as monolayer cultures in DMEM supplemented with 15% heat-inactivated FBS, 2 mM glutamine, 100 U/ml penicillin, and 100 mg/ml streptomycin (17) . RBL-2H3 cells (1 ϫ 10 7 cells) were transfected by electroporation with 20 g of pcDNA3 containing the receptor cDNAs. Geneticin-resistant cells were selected by FACS analysis and cloned into single cells. HMECs were grown in endothelial cell medium supplemented with 10% heat-inactivated FBS. Levels of receptor expression were monitored by FACS analysis.
FACS analysis
For flow cytometry, RBL cells were detached by Versene treatment, washed with HEPES-buffered HBSS, and resuspended in the same medium. Cells (1-5 ϫ 10 6 cells) were incubated with anti-CXCR1 or anti-CXCR2 Abs (1 g/ml) in a total volume of 400 l of HEPES-buffered HBSS for 60 min at 4°C. The cells were then washed and incubated with FITC-anti-mouse IgG for 60 min at 4°C and then analyzed for cell surface expression of the receptor on a BD Biosciences FACScan cytometer (5).
Radioligand-binding assays and receptor internalization
Radioligand-binding assays were conducted as described previously (5) . Briefly, RBL-2H3 cells were subcultured overnight in 24-well plates (0.5 ϫ 10 6 cells/well) in growth medium. Cells were then rinsed with DMEM supplemented with 20 mM HEPES (pH 7.4) and 10 mg/ml BSA and incubated on ice for 2-4 h in the same medium (250 l) containing 125 I-labeled CXCL8 (0.1-1 nM). Reactions were stopped with 1 ml of ice-cold PBS containing 10 mg/ml BSA and washed three times with the same buffer. The cells were then solubilized with 200 l of radioimmunoprecipitation assay buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate, and 0.1% SDS and dried under vacuum, and bound radioactivity was counted (18) . Nonspecific radioactivity bound was determined in the presence of 500 nM unlabeled WT CXCL8. K d and B max were determined using the GraphPad radioligand-binding data analysis. For competition binding, 125 I-labeled CXCL8 binding was carried out in the presence of different concentrations of ligands (0 -1 M). For receptor internalization, cells were incubated with ligand for 0 -60 min at 37°C. The cells were then washed with icecold PBS and 125 I-labeled CXCL8 binding (0.1-1 nM) was conducted as described above.
PI hydrolysis, ␤-hexosaminidase release, and intracellular calcium measurement RBL-2H3 cells were subcultured overnight in 96-well culture plates (50,000 cells/well) in inositol-free medium supplemented with 10% dialyzed FBS and 1 Ci/ml [ 3 H]inositol. The generation of inositol phosphates and ␤-hexosaminidase was determined as previously reported (5, 17, 19, 20) . For calcium mobilization, 5 ϫ 10 6 cells were washed with HEPES-buffered saline and loaded with 1 M Indo I-AM in the presence of 1 M pluronic acid for 30 min at room temperature. The cells were then washed with HEPES and resuspended in 1.5 ml of Siriganian buffer, and intracellular calcium levels for CXCL8 variants were measured as described previously (20) .
Chemotaxis RBL-2H3 cells or HMECs (50,000) were incubated at 37 o C with different concentrations of ligands. Chemotaxis was assessed in 48-well microchemotaxis chambers using polyvinylpyrrolidone-free 8-m pore size membranes. Migration was allowed to continue for 3 h at 37°C in humidified air containing 5% CO 2 . The membrane was removed and the upper surface was washed with PBS, scraped, fixed, and stained. For Ab pretreatment, HMECs were incubated with 10 g/ml anti-CXCR1, anti-CXCR2, or mouse IgG for 30 min as described previously (21, 22) . The results are represented as chemotactic index (mean number of cells per high-power field for chemokine dilution/mean number of cells per highpower field for medium (5) . The results are representative of three separate experiments.
Phosphorylation of receptors
Phosphorylation of receptors was performed as described previously (5, 18, 23) . RBL-2H3 cells (5 ϫ 10 6 ) expressing the receptors were incubated with [ 32 P]orthophosphate (150 Ci/dish) for 90 min. The labeled cells were then stimulated with the CXCL8 variants for 5 min at 37°C. Cells were then washed with ice-cold PBS and solubilized in 1 ml of radioimmunoprecipitation assay buffer. Cell lysates were immunoprecipitated with specific Abs against either the N terminus of CXCR1 or CXCR2 and analyzed by SDS electrophoresis and visualized by autoradiography.
␤-Arrestin (␤arr) translocation
RBL-2H3 cells stably expressing CXCR1 and CXCR2 were transfected with ␤arr-1-GFP by electroporation and plated on sterile 0.17-mm glass bottom dishes and grown overnight. The cells were washed twice with 2 ml of warm RPMI 1640 medium without phenol red-containing 10 mM HEPES. The experiments were carried in the same medium. The cells were observed under the microscope using an oil immersion ϫ60 objective lens. The fluorescence images of the live cells were collected using a TE-FM Epi-Fluorescence system attached to a Nikon Inverted Microscope Eclipse TE300 at 37°C at different time intervals (30 s for 1 h) in the presence or absence of ligand. All of the fluorescence images were captured by a cool snap HQ digital B/W CCD (Roper Scientific) camera. The fluorescence of GFP was detected with filter set S480/20x, S525/40m (no. 86007, EGFP/DsRed; Chroma Technology). All of the data were analyzed and images were pseudocolored using Metamorph 4.6r5 software (Universal Imaging) (23) .
Inhibition of GTPase activity
For desensitization, RBL-CXCR1 and RBL-CXCR2 (1 ϫ 10 7 cells/ml) were washed twice with PBS and treated with 100 nM of either CXCL8, L25NMe, or R26C for 5 min at 37 o C. The reaction was stopped by the addition of 10 ml of ice-cold PBS, cells were pelleted by centrifugation, and membranes were prepared as previously described (17, 18) . GTPase assays using 10 -20 g of membranes were measured at 30°C in buffer that contained 20 mM sodium-HEPES (pH 8.0), 25 mM NaCl, 0.1 mM EDTA, 1.0 mM MgCl 2 , 20 g/ml bovine albumin, 50 nM GDP, 100 nM [␥-32 P]GTP, and 100 nM CXCL8 (17, 18) . Basal activity ( 32 Pi released in the absence of CXCL8, 6 -10 pmol/mg of protein) has been subtracted from CXCL8-stimulated GTPase activity (15-20 pmol/mg of protein).
ERK phosphorylation
RBL-2H3 cells (5 ϫ 10 6 ) expressing the receptors were washed three times with PBS and then resuspended in PBS containing CXCL8 variants (100 nM) for different time intervals at 37°C. The reactions were stopped with ice-cold PBS and the centrifuged cells were lysed and assayed for protein concentration as described previously (23) . Proteins (ϳ50 g) were resolved by 10% SDS-PAGE, transferred to a nitrocellulose membrane, and probed with Ab against either ERK1/2 or phospho-ERK1/2 (23). Detection was conducted with HRP-conjugated sheep anti-mouse Ab and by ECL.
Results
Function of CXCL8 monomer and dimer for human neutrophils
To assess the ability of the monomeric and dimeric variants of CXCL8 to mediate cellular responses in human neutrophils, intracellular calcium mobilization was measured. As shown in Fig. 1 , the trapped monomer mediated greater intracellular Ca 2ϩ mobilization (EC 50 ϭ 0.5 Ϯ 0.2 nM) compared with the trapped dimer (EC 50 ϭ 7.1 Ϯ 0.1 nM). The WT CXCL8 showed an activity similar to the monomeric CXCL8 (EC 50 ϭ 1.5 Ϯ 0.1 nM).
CXCL8 monomer-and dimer-mediated CXCR1 and CXCR2 activation in RBL-2H3 cells
Since neutrophils express both CXCR1 and CXCR2, we sought to determine the effect of the trapped monomer and dimer ligands in RBL-2H3 cells stably expressing either CXCR1 (RBL-CXCR1) or CXCR2 (RBL-CXCR2). FACS analysis ( Fig. 2A ) and ligand-binding studies indicate that the cell lines express similar number of receptors (B max : 13,564 Ϯ 679 and 14,092 Ϯ 527 receptors/cell for RBL-CXCR1 and RBL-CXCR2, respectively). The receptors were previously shown to bind WT CXCL8 with similar affinities (K d : 4.7 Ϯ 0.1 and 2.5 Ϯ 0.1 nM for RBL-CXCR1 and RBL-CXCR2, respectively) to that of the native receptors in neutrophils (K d : 1-2 nM) (24) . Competitive binding studies with RBL-CXCR1 and RBL-CXCR2 showed that the receptors bound the monomer (K d : 2.9 Ϯ 0.1 and 1.7 Ϯ 0.1 nM for CXCR1 and CXCR2, respectively) with affinities similar to those of WT CXCL8 and bound the dimer (K d : 17.1 Ϯ 0.7 and 9.0 Ϯ 0.2 nM for CXCR1 and CXCR2, respectively) with lower affinities (Table I) . These results are consistent with those previously reported (9) .
We next measured the ability of the CXCL8 variants to mediate cellular responses in RBL-2H3 cells. As shown for the neutrophils, the trapped monomer mediated greater intracellular Ca 2ϩ mobilization in both RBL-CXCR1 and RBL-CXCR2 cells compared with the trapped dimer (Fig. 2B) . The CXCL8 variants also displayed dose-dependent PI hydrolysis and secretion of ␤-hexosaminidase. The potencies of the monomer and dimer were similar (EC 50 : ϳ20 and ϳ40 nM for PI hydrolysis and secretion of ␤-hexosaminidase, respectively), whereas the efficacies were different. The monomer, compared with the dimer, was more efficacious in eliciting both PI hydrolysis and ␤-hexosaminidase release, and the differences were observed to be more profound for the CXCR1 compared with the CXCR2 receptor. The relative efficacies of the monomer and dimer for PI hydrolysis are 5.9 Ϯ 0.4 and 2.0 Ϯ 0.4, respectively, in RBL-CXCR1 and 4.7 Ϯ 0.2 and 2.7 Ϯ 0.2, respectively in RBL-CXCR2 cells (Figs. 3, A and C) . The relative efficacies of the monomer and dimer for secretion of ␤-hexosaminidase are 13.5 Ϯ 0.8 and 4.5 Ϯ 0.2, respectively, in RBL-CXCR1 and 9.4 Ϯ 0.4 vs 4.3 Ϯ 0.4, respectively, in RBL-CXCR2 cells (Fig. 3, B and D) . WT CXCL8 showed intermediate efficacies in both assays.
We next measured the ability of the CXCL8 variants to induce chemotaxis in RBL-2H3 cells. The maximum chemotactic index was obtained at ϳ33 nM for both RBL-CXCR1 and RBL-CXCR2 (Fig. 3, E and F) . The monomer was more potent in mediating chemotaxis to CXCR1 (3.9 Ϯ 1.0) compared with the dimer (2 Ϯ 0.4) and WT CXCL8 (3.1 Ϯ 1.1). In contrast, the chemotactic response to CXCR2 was similar for all three CXCL8 variants (4.1 Ϯ 0.7, 3.8 Ϯ 0.2, and 3.6 Ϯ 0.4 for monomer, WT, and dimer, respectively; Fig. 3F ).
We also assessed the ability of CXCL8 variants to induce chemotaxis in HMECs that express both CXCR1 and CXCR2 receptors (22) . As shown in Fig. 3G , the potency of the monomer was greater than that of the dimer. HMECs pretreated with anti-CXCR2 or mouse IgG also displayed greater chemotaxis in response to the monomer than that of the dimer or WT CXCL8 (Fig. 3H ). HMECs pretreated with anti-CXCR1, however, displayed a similar chemotactic index (ϳ1.5) for all three CXCL8 variants (Fig. 3H) . These data mirrored the ones obtained with RBL-CXCR2 and further indicate that the dimer is as potent as the monomer in mediating chemotactic response to CXCR2.
CXCL8-induced receptor phosphorylation
To assess the ability of the CXCL8 variants to induce receptor phosphorylation, 32 P-labeled RBL-CXCR1 and RBL-CXCR2 cells were stimulated with CXCL8 variants and PMA as control. Both CXCL8 monomers and dimers induced phosphorylation of both CXCR1 and CXCR2 (Fig. 4A) . The receptors migrated as two forms: a high molecular mass form (ϳ70 and ϳ55 kDa for CXCR1 and CXCR2, respectively) and a low molecular mass form (ϳ50 and ϳ40 kDa for CXCR1 and CXCR2, respectively). The high molecular mass corresponds to the dimer and the low molecular mass to the monomer (25) . For CXCR1, the monomer induced greater phosphorylation than the dimer, whereas for CXCR2, both monomers and dimers induced receptor phosphorylation to a similar extent (Fig. 4, B and C) . PMAinduced heterologous phosphorylation of CXCR1 and CXCR2 was significantly lower than the CXCL8 variants. 
Receptor internalization
Both CXCL8 monomer and dimer induced internalization of CXCR1 and CXCR2 in a time-dependent manner (Fig. 5) . Monomer-induced CXCR1 internalization was faster than that of the dimer (ϳ70% vs 30% after 15 min; Fig. 5A ), whereas both forms of CXCL8 induced rapid CXCR2 internalization (ϳ95% after 5 min; Fig. 5B ).
The WT showed intermediate activity for CXCR1 and the same activity as monomer and dimer for CXCR2.
Both receptors have been shown to internalize via an arrestindependent mechanism (5, 10). To assess the time dependency of CXCR1 and CXCR2-mediated arrestin recruitment, a GFPtagged ␤arr-1 was transiently expressed in RBL-CXCR1 and RBL-CXCR2 cells. Fluorescence microscopy was used to study the time course of arrestin translocation to the cell surface and internalization. The monomer, but not the dimer, induced ␤arr-1 translocation to the cell membrane in RBL-CXCR1 cells. In contrast, both monomer and dimer induced ␤arr-1 translocation in RBL-CXCR2 cells (Fig. 6) . The WT behaved like the monomer in RBL-CXCR1 cells and like both the monomer and dimer in RBL-CXCR2 cells. 
CXCL8-mediated ERK activation
To determine the ability of the CXCL8 variants to activate downstream signals in RBL-2H3 cells, we measured ERK1/2 phosphorylation. Both monomer and dimer activate CXCR1 and CXCR2 to induce time-dependent phosphorylation of ERK1/2 (Fig. 7, A, D, and G). Maximum responses were obtained at 1-2 min. CXCR2-induced ERK1/2 phosphorylation (Fig. 7, C, F, and I) , however, was more sustained than that of CXCR1 (Fig. 7, B, E, and H) .
Receptor desensitization
Intracellular Ca 2ϩ mobilization in intact cells was measured to assess receptor desensitization. Cells were first exposed to different concentrations of CXCL8 variants (0 -100 nM) and rechallenged 3 min later with 10 nM WT CXCL8. As shown in Fig. 8 , all forms of CXCL8 desensitized intracellular Ca 2ϩ mobilization to WT CXCL8 in a dose-dependent fashion. Monomer-mediated desensitization of CXCR1 was more potent than that of dimer (EC 50 ϭ 0.9 vs 5.6 nM; Fig. 8A ). In contrast, both monomer and dimer desensitized CXCR2 with similar potencies (EC 50 : ϳ1 nM; Fig.  8B ). The WT CXCL8 showed intermediate activity for CXCR1 and the same activity as monomer and dimer for CXCR2.
To further assess the ability of the monomeric and dimeric forms of CXCL8 to mediate receptor desensitization, CXCL8-induced G protein activation in membrane preparations was measured. Pretreatment of RBL-CXCR1 cells with the monomer caused significantly higher inhibition of GTPase activity than the dimer (ϳ60% vs ϳ22%; Fig. 8C ). In contrast, both the monomer and dimer were equally potent in inhibiting GTPase activity in RBL-CXCR2 (ϳ65%). Similar to desensitizing Ca 2ϩ release activity, the WT showed intermediate GTPase inhibition for CXCR1 and the same as the monomer and dimer for CXCR2.
Phosphorylation and internalization of the CXCR2 mutant B D199V A
The CXCR2 mutant B D199V A, in which aspartate 199 of CXCR2 was substituted for its valine counterpart of CXCR1, was shown to internalize like CXCR1 upon exposure to WT CXCL8 (24) . To further assess the role of the monomeric and dimeric forms of CXCL8 in receptor functions, we measured B D199V A phosphorylation. 32 P-labeled RBL-CXCR2 and RBL-B D199V A cells were stimulated with monomer, dimer, and WT. As expected, all three variants induced phosphorylation of CXCR2 to similar extent (Fig.  9A, left panel) . For B D199V A, however, the monomer induced greater phosphorylation than the dimer and WT (Fig. 9A, right  panel) .
To correlate receptor phosphorylation with internalization, we measured 125 I-labeled CXCL8 binding in cells pretreated with monomer, dimer, or WT CXCL8. All three ligands induced rapid CXCR2 internalization (ϳ95% after 5 min; Fig. 9B ). Monomerinduced B D199V A internalization, however, was faster than that of the dimer (ϳ60% vs 25% after 15 min). The WT showed intermediate activity (Fig. 9C) .
Discussion
CXCL8 is a member of the ELR (Glu-Leu-Arg) subfamily of chemokines that forms noncovalent-associating dimers under physiological conditions. Neutrophils express two CXCL8 receptors, CXCR1 and CXCR2, at similar levels (26, 27) . Previous studies using trapped monomer and dimer have indicated that the monomer is the high-affinity ligand and the dimer is the low-affinity ligand for both receptors (9). CXCL8 binding elicits Ca 2ϩ release and chemotaxis for both receptors but only CXCR1 mediates phospholipase D activation and respiratory burst (26, 28) . These observations indicate that the two receptors could have unique roles for in vivo fine-tuning of CXCL8-mediated neutrophil recruitment and inflammatory response. To date, little is known concerning the role of the CXCL8 monomer and dimer in regulating neutrophil responses to CXCR1 and CXCR2. The data herein, using a trapped monomer and a trapped dimer, demonstrate that although the monomer/dimer equilibrium modulates CXCR1 and CXCR2 activation in a similar fashion (i.e., monomerϾWTϾdimer), it differs in its ability to mediate receptor desensitization and down-regulation. This contention is supported by the following observation. First, the monomer, compared with the dimer, is more efficacious for CXCR1 and CXCR2 receptors in mediating PI hydrolysis, secretion of ␤-hexosaminidase, and intracellular Ca 2ϩ mobilization (Figs. 1-3) . Second, the dimer is as active as the monomer in inducing CXCR2, but not CXCR1, phosphorylation, desensitization, and internalization (Figs. 4 -6 and 8) . Similar CXCR2-related activities of the monomer and dimer, despite reduced binding affinities, indicate that the binding affinities are not correlated to function. Binding affinity is an equilibrium measurement (K d ϭ k off /k on ) and it is very possible that function is determined not by K d but by the lifetime (l/k off ) of the ligand-bound receptor complex. We propose that the monomer and dimer have similar k off values and therefore similar activities.
CXCR1 is a high-affinity receptor only for CXCL8, whereas CXCR2 binds seven different chemokines (CXCL1-3, 5-8) with similar high affinity to mediate neutrophil responses. It is well established that CXCR2 is a promiscuous receptor and is less sensitive to mutations, and therefore it is not surprising that binding of both the monomer and dimer induces the conformational change necessary for the receptor to be fully recognized by G proteincoupled receptor kinases and undergo phosphorylation, desensitization, and internalization. Supporting this contention is that the CXCR2 mutant B D199V A in which aspartic 199 was exchanged for the valine counterpart of CXCR1 and was shown to desensitize and internalize like CXCR1(24) displayed partial dimer-mediated phosphorylation and internalization similar to that of CXCR1 (Fig. 9) .
In addition to termination of GPCR-mediated signaling, ␤arrs also act as scaffold proteins by forming complexes with other proteins, which upon receptor activation and/or internalization activate downstream effector systems such as MAPK, tyrosine kinase, and growth factors (29 -32) . Upon CXCR2 activation, all CXCL8 variants induced rapid ␤arr1 translocation to the cell membrane and receptor internalization. These data likely indicate a greater ability of the CXCR2 to activate postendocytic signals in response to CXCL8. Indeed, CXCR2-mediated ERK1/2 activation was sustained for both the monomer and dimer, whereas responses to CXCR1 were transient (Fig. 7) . Interestingly, despite the inability of the dimer to induce ␤arr-1 translocation to CXCR1 (Fig. 6) , it mediates ERK1/2 activation to the same extent as the monomer. RBL-2H3 cells express ␤arr-1 and ␤arr-2 (33). CXCR1 and CXCR2 couple to both isoforms to internalize and regulate cellular responses (10, 20, 29, 31, 34) . One explanation could be that the lower phosphorylated form of CXCR1 in response to the dimer couples to ␤arr-2 to activate ERK1/2. However, expression of ␤arr-2-GFP in RBL-CXCR1 showed no GFP translocation to the cell membrane in response to dimer activation (data not shown). Another explanation could be that CXCR1 couples to a ␤-arrestinindependent mechanism to mediate ERK1/2 activation.
Previous studies from our laboratory and others have shown that receptor phosphorylation and internalization play an important role in CXCL8-mediated chemotactic and cytotoxic activities (5, (35) (36) (37) (38) . CXCR1 and CXCR2 mutants deficient in receptor phosphorylation and internalization displayed impaired chemotaxis but greater cellular responses (i.e., PI hydrolysis, intracellular Ca 2ϩ mobilization, and exocytosis) compared with WT CXCR2 (5). Thus, the ability of the CXCL8 variants to induce receptor phosphorylation and internalization should correlate with their ability to mediate chemotaxis. Indeed, both the CXCL8 monomer and dimer induced RBL-CXCR2 chemotaxis to a similar extent, whereas the monomer was significantly more potent in inducing RBL-CXCR1 chemotaxis compared with the dimer (Fig. 3, E and  F) . Furthermore, HMECs pretreated with anti-CXCR1 or anti-CXCR2 displayed similar results (Fig. 3H) .
A large number of GPCRs, including CXCR1 and CXCR2, exist as both monomer and dimer in the cell membrane (39) . Oligomerization of GPCRs can be ligand dependent or ligand independent (25) . The CXCL8 receptor dimerization is ligand independent and occurs in the endoplasmic reticulum (25, 39) . However, both forms of the receptor seem to be capable of interacting with ligand to induce cellular responses (39) . A question that remains to be addressed is whether the CXCL8 monomer and dimer have a binding preference. For instance, does the monomeric ligand preferentially interact with the monomeric form and the dimer with the dimeric form of the receptors? Does the equilibrium monomer-dimer modulate receptor functions by temporally activating a specific form of the receptor vs the others? Our attempt to stably coexpress receptor mutants deficient in receptor dimerization along with WT CXCR2 in RBL-2H3 cells to address these questions was not successful. The receptor mutants were either expressed very poorly (Y49-CXCR2), failed to express (D143-CXCR2), or displayed decreased affinity for ligand (A315-CXCR2) compared with WT receptors. In addition, we reasoned that the changes in the structural and pharmacological properties of the receptors will likely complicate the interpretation of the results in terms of the monomerdimer equilibrium. In addition to CXCL8 homodimerization, recent studies have also shown that CXCL8 can form heterodimers with other chemokines such as platelet factor 4 or CXCL4 (40) . Whether or not CXCL8 heterodimerization has any physiological consequences or plays a role in CXCR1 and CXCR2 activation and regulation remains unclear. CXCL8 function also involves binding to glycosaminoglycans on endothelial cells and extracellular matrix, and it is believed such binding promotes formation of a concentration gradient for neutrophil migration to the site of inflammation (41) . CXCL8 dimers bind glycosaminoglycans with higher affinity, and we have recently observed in a mouse model that the CXCL8 dimer is more active in recruiting neutrophils at relatively high concentrations (unpublished data). These observations further emphasize that the ability to reversibly exist as monomers and dimers play a critical role in regulating in vivo neutrophil function.
On the basis of our data and from previous studies, we now propose a model as to how differential interactions of CXCL8 monomers and dimers for CXCR1 and CXCR2 receptors mediate neutrophil function. Neutrophil recruitment involves continuous engagement with both receptors for multiple functions from cell shape change, chemotaxis, to cytotoxic events such as release of proteases and superoxide. These events have to be spatially and temporally coordinated because initial receptor engagement should lead to recruitment and chemotaxis, and receptor engagement leading to cytotoxic event should not be triggered until late at the site of infection. Therefore, recruitment and activation of neutrophils should be highly coordinated for successful resolution of inflammation. It is critical that conditions that favor triggering cytotoxic effects are disfavored during the early stages and favored at the final stages of recruitment. During early stages of recruitment, CXCR2 plays a more active role due its intrinsic higher activity, and once CXCR2 is depleted due to exocytosis, CXCR1 could become engaged and/or remain relatively inactive during the early stages of trafficking. At the site of infection, it is very likely that only CXCR1 is available on the cell surface and its activation results in cytotoxic events such as release of proteases and superoxide. The lower activity of the dimer for these activities also indicate that dimerization negatively regulates these function to destroy bacteria and minimize any collateral tissue damage. In summary, we propose that the ability of CXCL8 to reversibly exist as monomers and dimers and their differential activities and regulation for the CXCR1 and CXCR2 receptors play an essential role in all aspects of inflammatory response from recruiting neutrophils to the site of infection to trigger cytotoxic activities such as release of protease and oxygen radicals to eliminate infection.
